PropertyValue
?:definition
  • Molecular assay reagents intended to identify gene variants associated with hyperparathyroidism, a condition characterized by elevated levels of parathyroid hormone (PTH) that may be caused by parathyroid hyperplasia or parathyroid neoplasms (i.e., primary hyperparathyroidism) or by increased PTH secretion in response to hypocalcemia (i.e., secondary hyperparathyroidism). Genetic variants at multiple loci have been associated with hyperparathyroidism. These reagents are intended to detect various types of genetic changes (e.g., deletions, duplications, insertions, single nucleotide polymorphisms) in multiple hyperparathyroidism-associated loci simultaneously.
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C4730269_UMD>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C4730269_UMD>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all